Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers

Neurodegenerative, inflammatory and neoplastic brain disorders involve neuroinflammatory reactions, and a biomarker of neuroinflammation would be useful for diagnostic, drug development and therapy control of these frequent diseases. In vivo imaging can document the expression of the peripheral benzodiazepine receptor (PBR)/translocator protein 18 kDa (TSPO) that is linked to microglial activation and considered a hallmark of neuroinflammation. The prototype positron emission tomography tracer for PBR, [11C]PK11195, has shown limitations that until now have slowed the clinical applications of PBR imaging. In recent years, dozens of new PET and SPECT radioligands for the PBR have been radiolabelled, and several have been evaluated in imaging protocols. Here we review the new PBR ligands proposed as challengers of [11C]PK11195, critically analyze preclinical imaging studies and discuss their potential as neuroinflammation imaging agents.

[1]  B. Gulyás,et al.  [11C]Vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies , 2005, Journal of the Neurological Sciences.

[2]  R. Butterworth,et al.  Characterization of binding sites for the omega3 receptor ligands [3H]PK11195 and [3H]RO5-4864 in human brain. , 1997, European journal of pharmacology.

[3]  A. Guidotti,et al.  2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). , 1992, The Journal of pharmacology and experimental therapeutics.

[4]  M. Plotkine,et al.  Induction of Type 2 Iodothyronine Deiodinase in Astrocytes after Transient Focal Cerebral Ischemia in the Rat , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  Chester A. Mathis,et al.  The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: Implications for PET imaging , 2007, Experimental Neurology.

[6]  E. Novellino,et al.  N,N-dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral benzodiazepine receptor. , 2004, Journal of medicinal chemistry.

[7]  P. Santens,et al.  Cobalt-55 positron emission tomography in vascular dementia: significance of white matter changes , 2001, Journal of the Neurological Sciences.

[8]  G. Rosenberg.  Matrix metalloproteinases in neuroinflammation , 2002, Glia.

[9]  M. Goodman,et al.  Synthesis, fluorine-18 radiolabeling, and in vitro characterization of 1-iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinoline carboxamide derivatives as potential PET radioligands for imaging peripheral benzodiazepine receptor. , 2008, Bioorganic & medicinal chemistry.

[10]  Richard S. J. Frackowiak,et al.  In Vivo Binding to Peripheral Benzodiazepine Binding Sites in Lesioned Rat Brain: Comparison Between [3H]PK11195 and [18F]PK14105 as Markers for Neuronal Damage , 1990, Journal of neurochemistry.

[11]  Ronald Boellaard,et al.  Evaluation of Methods for Generating Parametric (R)-[11C]PK11195 Binding Images , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  M. Grégoire,et al.  Improved synthesis of the peripheral benzodiazepine receptor ligand [11C]DPA-713 using [11C]methyl triflate. , 2006, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[13]  S. Meikle,et al.  Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand. , 2005, Bioorganic & medicinal chemistry.

[14]  R B Banati,et al.  The concept of in vivo imaging of neuroinflammation with [11C](R)-PK11195 PET. , 2002, Ernst Schering Research Foundation workshop.

[15]  Ronald Boellaard,et al.  Evaluation of Reference Regions for (R)-[11C]PK11195 Studies in Alzheimer's Disease and Mild Cognitive Impairment , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  M. Welch,et al.  Radiosynthesis, in vitro validation, and in vivo evaluation of 18F-labeled COX-1 and COX-2 inhibitors. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  R. V. Van Heertum,et al.  A general method for the synthesis of aryl [11C]methylsulfones: potential PET probes for imaging cyclooxygenase-2 expression. , 2005, Bioorganic & medicinal chemistry letters.

[18]  M. Reinhardt,et al.  Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ) , 2005, NeuroImage.

[19]  C. Dence,et al.  Synthesis, in vivo evaluation and PET study of a carbon-11-labeled neuronal nitric oxide synthase (nNOS) inhibitor S-methyl-L-thiocitrulline. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  P. Soubrié,et al.  SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair. , 2002, The Journal of pharmacology and experimental therapeutics.

[21]  C. Carter,et al.  Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage , 1987, Brain Research.

[22]  B. Gulyás,et al.  Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  P. Trouillas,et al.  Inflammatory Response After Ischemic Stroke , 2007 .

[24]  P. Metz,et al.  Synthesis of 18F-labelled cyclooxygenase-2 (COX-2) inhibitors via Stille reaction with 4-[18F]fluoroiodobenzene as radiotracers for positron emission tomography (PET). , 2005, Organic & biomolecular chemistry.

[25]  B. Blom,et al.  Down-regulation of the macrophage lineage through interaction with OX2 (CD200). , 2000, Science.

[26]  Tetsuya Suhara,et al.  A comparison of the high‐affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)‐PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation , 2007, Journal of neurochemistry.

[27]  F. Yasuno,et al.  Increased Binding of Peripheral Benzodiazepine Receptor in Alzheimer's Disease Measured by Positron Emission Tomography with [11C]DAA1106 , 2008, Biological Psychiatry.

[28]  Synthesis and in vitro binding of N,N-dialkyl-2-phenylindol-3-yl-glyoxylamides for the peripheral benzodiazepine binding sites. , 2006, Bioorganic & medicinal chemistry.

[29]  F. Fazio,et al.  Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors. , 2001, Journal of medicinal chemistry.

[30]  P. Barber,et al.  MR molecular imaging of early endothelial activation in focal ischemia , 2004, Annals of neurology.

[31]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[32]  D J Brooks,et al.  Microglial activation correlates with severity in Huntington disease , 2006, Neurology.

[33]  David K. Menon,et al.  Intrinsic Activated Microglia Map to the Peri-infarct Zone in the Subacute Phase of Ischemic Stroke , 2006, Stroke.

[34]  Tetsuya Suhara,et al.  11C-AC-5216: A Novel PET Ligand for Peripheral Benzodiazepine Receptors in the Primate Brain , 2007, Journal of Nuclear Medicine.

[35]  S. Kurumiya,et al.  Antianxiety and antidepressant‐like effects of AC‐5216, a novel mitochondrial benzodiazepine receptor ligand , 2004, British journal of pharmacology.

[36]  V. Perry,et al.  Differential Blood–Brain Barrier Breakdown and Leucocyte Recruitment Following Excitotoxic Lesions in Juvenile and Adult Rats , 1998, Experimental Neurology.

[37]  R. Myers,et al.  The radiosynthesis of [18F]PK 14105 as an alternative radioligand for peripheral type benzodiazepine binding sites. , 1990, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[38]  Ryuji Nakao,et al.  Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  P. Sherman,et al.  Synthesis and Evaluation of [123I]-Iodo-PK11195 for Mapping Peripheral-Type Benzodiazepine Receptors (ω3) in Heart , 1996 .

[40]  J. Korf,et al.  55Cobalt (Co) as a PET-tracer in stroke, compared with blood flow, oxygen metabolism, blood volume and gadolinium-MRI , 1999, Journal of the Neurological Sciences.

[41]  Alexander Hammers,et al.  In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease , 2006, Neurobiology of Disease.

[42]  Yuji Nagai,et al.  Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain , 2004, Synapse.

[43]  Thomas Walther,et al.  Transgenic rat model of Huntington's disease. , 2003, Human molecular genetics.

[44]  D. Nutt,et al.  Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. , 2006, Trends in pharmacological sciences.

[45]  P. Blower,et al.  Imaging hypoxia in vivo by controlling the electrochemistry of copper radionuclide complexes , 2007 .

[46]  B. Gómez-Anson,et al.  Radiolabeled leucocyte imaging in diffuse granulomatous involvement of the meninges in Wegener's granulomatosis: scintigraphic findings and their role in monitoring treatment response to specific immunotherapy (humanized monoclonal antilymphocyte antibodies). , 2000, AJNR. American journal of neuroradiology.

[47]  C. Pert,et al.  Chemokine receptor 5 antagonist d-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease , 2005, Neuroscience.

[48]  F. Turkheimer,et al.  Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study , 2004, Neurobiology of Disease.

[49]  B. Ponsard.  Production of radioisotopes in the BR2 high-flux reactor for applications in nuclear medicine and industry† , 2007 .

[50]  J. Saavedra,et al.  The Discovery of a Novel Macrophage Binding Site , 2006, Cellular and Molecular Neurobiology.

[51]  R. V. Van Heertum,et al.  Synthesis and in vivo evaluation of [18F]-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide as a PET imaging probe for COX-2 expression. , 2007, Bioorganic & medicinal chemistry.

[52]  Alexander Gerhard,et al.  In vivo imaging of neuroinflammation , 2002, European Neuropsychopharmacology.

[53]  Kengo Ito,et al.  Radiosynthesis and in vivo evaluation of N-[11C]methylated imidazopyridineacetamides as PET tracers for peripheral benzodiazepine receptors. , 2008, Nuclear medicine and biology.

[54]  Sylvain Houle,et al.  Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. , 2008, Nuclear medicine and biology.

[55]  J. Alcocer-Varela,et al.  Is damage in central nervous system due to inflammation? , 2003, Autoimmunity reviews.

[56]  T. Kielian,et al.  Effects of neuroinflammation on glia–glia gap junctional intercellular communication: a perspective , 2004, Neurochemistry International.

[57]  F. Turkheimer,et al.  Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[58]  Robert B. Innis,et al.  Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation , 2008, NeuroImage.

[59]  B. Trapp,et al.  VCAM‐1‐Positive Microglia Target Oligodendrocytes at the Border of Multiple Sclerosis Lesions , 2002, Journal of neuropathology and experimental neurology.

[60]  A. van Waarde,et al.  Synthesis and in vivo evaluation of 18F-desbromo-DuP-697 as a PET tracer for cyclooxygenase-2 expression. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[61]  R. Sterzi,et al.  Technetium-99m hexamethylpropylene amine oxime leucocyte scintigraphy in the differential diagnosis of cerebral abscesses , 2000, European Journal of Nuclear Medicine.

[62]  F. Fazio,et al.  Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration , 2004, Neurochemistry International.

[63]  B. Lopresti,et al.  The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imaging , 2006, Progress in Neurobiology.

[64]  D. Spray,et al.  Connexin43, the major gap junction protein of astrocytes, is down‐regulated in inflamed white matter in an animal model of multiple sclerosis , 2005, Journal of neuroscience research.

[65]  G. L. Watkins,et al.  PET Imaging of human gliomas with ligands for the peripheral benzodiazepine binding site , 1989, Annals of neurology.

[66]  Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study. , 2002, Nuclear medicine and biology.

[67]  Philippe Hantraye,et al.  11C-DPA-713: A Novel Peripheral Benzodiazepine Receptor PET Ligand for In Vivo Imaging of Neuroinflammation , 2007, Journal of Nuclear Medicine.

[68]  J. Seibyl,et al.  Synthesis and receptor binding studies of halogenated N,N-dialkylel-(2-phenyl-1H-indol-3-yl)glyoxylamides to visualize peripheral benzodiazepine receptors with SPECT or PET. , 2006, Bioorganic & medicinal chemistry.

[69]  M. Beal,et al.  Chronic quinolinic acid lesions in rats closely resemble Huntington's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[70]  Kortaro Tanaka,et al.  Enhanced Expression of Iba1, Ionized Calcium-Binding Adapter Molecule 1, After Transient Focal Cerebral Ischemia In Rat Brain , 2001, Stroke.

[71]  N. Déglon,et al.  Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum. , 2003, Human molecular genetics.

[72]  M. James,et al.  Development of ligands for the peripheral benzodiazepine receptor. , 2006, Current medicinal chemistry.

[73]  E. Warburton,et al.  Strategy for improved [11C]DAA1106 radiosynthesis and in vivo peripheral benzodiazepine receptor imaging using microPET, evaluation of [11C]DAA1106 , 2007 .

[74]  S. Hume,et al.  Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. , 1994, Nuclear medicine and biology.

[75]  Andreas Saleh,et al.  Imaging Inflammation in Acute Brain Ischemia , 2007, Stroke.

[76]  M. Pomper,et al.  Radiolabeled neuronal nitric oxide synthase inhibitors: synthesis, in vivo evaluation, and primate PET studies. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[77]  A. Lees,et al.  Dopamine neurotransmission, Parkinson’s disease and SPET , 2001, European Journal of Nuclear Medicine and Molecular Imaging.

[78]  Masahiro Fujita,et al.  Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors , 2008, NeuroImage.

[79]  S. Miller,et al.  Innate and adaptive immune responses of the central nervous system. , 2006, Critical reviews in immunology.

[80]  Sami S Zoghbi,et al.  Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo. , 2008, Journal of medicinal chemistry.

[81]  T. Suhara,et al.  [18F]FMDAA1106 and [18F]FEDAA1106: two positron-emitter labeled ligands for peripheral benzodiazepine receptor (PBR). , 2003, Bioorganic & medicinal chemistry letters.

[82]  Ryuji Nakao,et al.  Quantitative Analysis for Estimating Binding Potential of the Peripheral Benzodiazepine Receptor with [11C]DAA1106 , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[83]  Denis Guilloteau,et al.  DPA-714, a New Translocator Protein–Specific Ligand: Synthesis, Radiofluorination, and Pharmacologic Characterization , 2008, Journal of Nuclear Medicine.

[84]  R. Boellaard,et al.  Evaluation of Reference Tissue Models for the Analysis of [11C](R)-PK11195 Studies , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[85]  W. Brück,et al.  A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. , 2006, Brain : a journal of neurology.

[86]  Synthesis of substituted [123I]imidazo[1,2-α]pyridines as potential probes for the study of the peripheral benzodiazepine receptors using SPECT , 2000 .

[87]  J C Baron,et al.  Brain kinetics and specific binding of [11C]PK 11195 to omega 3 sites in baboons: positron emission tomography study. , 1991, European journal of pharmacology.

[88]  André Syrota,et al.  Synthesis of N‐(11C) methyl, N‐(methyl‐1 propyl), (chloro‐2 phenyl)‐1 isoquinoleine carboxamide‐3 (PK 11195): A new ligand for peripheral benzodiazepine receptors , 1984 .

[89]  A. Blamire,et al.  MRI detection of early endothelial activation in brain inflammation , 2004, Magnetic resonance in medicine.

[90]  Tetsuya Suhara,et al.  Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain. , 2004, Journal of medicinal chemistry.

[91]  Ronald Boellaard,et al.  Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[92]  Synthesis and evaluation of N-(5-fluoro-2-phenoxyphenyl)-N-(2-[(18)F]fluoromethoxy-d(2)-5-methoxybenzyl)acetamide: a deuterium-substituted radioligand for peripheral benzodiazepine receptor. , 2005, Bioorganic & medicinal chemistry.

[93]  B. Gulyás,et al.  Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients , 2008, Journal of the Neurological Sciences.

[94]  Tetsuya Suhara,et al.  [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. , 2003, Nuclear medicine and biology.

[95]  Carles Justicia,et al.  Anti-VCAM-1 Antibodies did not Protect against Ischemic Damage Either in Rats Or in Mice , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[96]  Y. Imai,et al.  Expression of CD200 by macrophage-like cells in ischemic core of rat brain after transient middle cerebral artery occlusion , 2007, Neuroscience Letters.

[97]  F. Mattner,et al.  Evaluation of a radiolabelled peripheral benzodiazepine receptor ligand in the central nervous system inflammation of experimental autoimmune encephalomyelitis: a possible probe for imaging multiple sclerosis , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[98]  J. Korf,et al.  Cobalt-57 and technetium-99m-HMPAO-labeled leukocytes for visualization of ischemic infarcts. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[99]  Tetsuya Suhara,et al.  Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography , 2007, The Journal of Neuroscience.

[100]  Ming-Kai Chen,et al.  Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. , 2008, Pharmacology & therapeutics.

[101]  Eric Achten,et al.  Assessment of Neuroinflammation and Microglial Activation in Alzheimer’s Disease with Radiolabelled PK11195 and Single Photon Emission Computed Tomography , 2003, European Neurology.

[102]  Dick J. Veltman,et al.  SPM analysis of parametric (R)-[11C]PK11195 binding images: Plasma input versus reference tissue parametric methods , 2007, NeuroImage.

[103]  Akiko Hatori,et al.  In vitro and ex vivo autoradiography studies on peripheral-type benzodiazepine receptor binding using [11C]AC-5216 in normal and kainic acid-lesioned rats , 2007, Neuroscience Letters.

[104]  Ming-Rong Zhang,et al.  [2-11C]isopropyl-, [1-11C]ethyl-, and [11C]methyl-labeled phenoxyphenyl acetamide derivatives as positron emission tomography ligands for the peripheral benzodiazepine receptor: radiosynthesis, uptake, and in vivo binding in brain. , 2006, Journal of medicinal chemistry.

[105]  K. Mardon,et al.  Pharmacological evaluation of an [(123)I] labelled imidazopyridine-3-acetamide for the study of benzodiazepine receptors. , 2006, Life sciences.

[106]  Tetsuya Suhara,et al.  Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor , 2007, Brain Research.

[107]  Ralph Weissleder,et al.  Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis , 2006, Circulation.

[108]  J. Korf,et al.  The significance of cobalt-55 positron emission tomography in ischemic stroke. , 1999, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[109]  B. Gulyás,et al.  Brain Uptake and Plasma Metabolism of [11C]Vinpocetine: A Preliminary PET Study in a Cynomolgus Monkey , 1999, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[110]  Radiosynthesis of 2‐[6‐chloro‐2‐(4‐iodophenyl)imidazo[1,2‐a]pyridin‐3‐yl]‐N‐ethyl‐N‐[11C]methyl‐acetamide, [11C]CLINME, a novel radioligand for imaging the peripheral benzodiazepine receptors with PET , 2007 .

[111]  R. Banati,et al.  Visualising microglial activation in vivo , 2002, Glia.

[112]  Robert B. Innis,et al.  PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat , 2007, Neuroscience Letters.

[113]  W. I. McDonald,et al.  Heterogeneity of blood‐brain barrier changes in multiple sclerosis , 1990, Neurology.

[114]  G. Schmid-Schönbein,et al.  Analysis of inflammation. , 2006, Annual review of biomedical engineering.

[115]  B. Kiss,et al.  PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects , 2002, Acta neurologica Scandinavica.

[116]  Masahiro Fujita,et al.  Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain , 2007, Synapse.

[117]  U. Dirnagl,et al.  Inflammation in stroke: the good, the bad, and the unknown. , 2004, Ernst Schering Research Foundation workshop.

[118]  S. Jan,et al.  In vivo imaging of brain lesions with [11C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors , 2007, Glia.

[119]  G. Biggio,et al.  2‐Phenyl‐imidazo[1,2‐a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats , 1999, British journal of pharmacology.

[120]  P Ferrara,et al.  Site-directed mutagenesis of the peripheral benzodiazepine receptor: identification of amino acids implicated in the binding site of Ro5-4864. , 1994, Molecular pharmacology.

[121]  N. Simonian,et al.  Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. , 1996, Stroke.

[122]  A G Sorensen,et al.  The Use of Imaging in the Early Development of Neuropharmacological Drugs: A Survey of Approved NDAs , 2008, Clinical pharmacology and therapeutics.

[123]  F. Fazio,et al.  Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors. , 2006, Bioorganic & medicinal chemistry.

[124]  M. Wirenfeldt,et al.  Microglial cell population dynamics in the injured adult central nervous system , 2005, Brain Research Reviews.

[125]  M. Welch,et al.  Synthesis and evaluation of two positron-labeled nitric oxide synthase inhibitors, S-[11C]methylisothiourea and S-(2-[18F]fluoroethyl)isothiourea, as potential positron emission tomography tracers. , 1996, Journal of medicinal chemistry.

[126]  Alexander Hammers,et al.  A systematic comparison of kinetic modelling methods generating parametric maps for [11C]-(R)-PK11195 , 2007, NeuroImage.

[127]  Blood flow dependence of the intratumoral distribution of peripheral benzodiazepine receptor binding in intact mouse fibrosarcoma. , 2006, Nuclear medicine and biology.

[128]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[129]  W. Vaalburg,et al.  Synthesis and evaluation of a fluorine-18 labeled antisense oligonucleotide as a potential PET tracer for iNOS mRNA expression. , 2004, Nuclear medicine and biology.

[130]  B. Weissman,et al.  Peripheral benzodiazepine receptors: on mice and human brain imaging , 2003, Journal of neurochemistry.

[131]  G. Fur,et al.  Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization , 1983, Journal of neurochemistry.

[132]  R. Landmann,et al.  Toll-Like Receptor 2 Signaling in Response to Brain Injury: An Innate Bridge to Neuroinflammation , 2006, The Journal of Neuroscience.

[133]  A. Katsifis,et al.  Synthesis of [123I]iodine labelled imidazo[1,2-b] pyridazines as potential probes for the study of peripheral benzodiazepine receptors using SPECT , 2004 .

[134]  Jordi Llop,et al.  Imaging Brain Inflammation with [11C]PK11195 by PET and Induction of the Peripheral-Type Benzodiazepine Receptor after Transient Focal Ischemia in Rats , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[135]  Tony Wyss-Coray,et al.  Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.